APOE2 reduces risk of Alzheimer's disease by protection of lysosomes from lipid overloading
Saved in:
| Main Authors: | Jing Feng, Xiwen Ma, Jianping Ye |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525001200 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microglial ApoD‐induced NLRC4 inflammasome activation promotes Alzheimer's disease progression
by: Yaliang Yu, et al.
Published: (2025-05-01) -
Accelerated midlife endocrine and bioenergetic brain aging in APOE4 females
by: Tian Wang, et al.
Published: (2025-08-01) -
Hypertension a Predictive Risk Factor on Progression to Alzheimer’s Disease Using APOEε4 as a Benchmark
by: Mingfei Li, et al.
Published: (2025-04-01) -
Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides
by: Anthony J Hinrich, et al.
Published: (2016-02-01) -
When Two Worlds Collide: The Contribution and Association Between Genetics (APOEε4) and Neuroinflammation (IL-1β) in Alzheimer’s Neuropathogenesis
by: Jagadeesh Narasimhappagari, et al.
Published: (2025-08-01)